首页> 美国卫生研究院文献>International Journal of Hematology-Oncology and Stem Cell Research >Follicular Dendritic Cell Sarcoma of Lymph Node: A report of a Patient with Chronic Myeloid Leukemia Treated with Imatinib
【2h】

Follicular Dendritic Cell Sarcoma of Lymph Node: A report of a Patient with Chronic Myeloid Leukemia Treated with Imatinib

机译:淋巴结滤泡性树突状细胞肉瘤:伊马替尼治疗慢性粒细胞白血病患者的报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Follicular dendritic cells or dendritic reticulum cells are important components of the immune system essential for antigen presentation. Malignancies arising from these cells are uncommon and the first case was reported in 1986. The most common sites of follicular dendritic cell sarcomas are lymph nodes, especially cervical, axillary and mediastinal regions, but extranodal sites including head and neck and gastrointestinal tract may be affected in one-third of patients. Immunohistochemistry plays an important role in its diagnosis to differentiate it from morphologically similar malignancies The present report describes a case of follicular dendritic cell sarcoma in a patient with chronic myeloid leukemia (CML) treated with imatininb mesylate for 6 years. This case deserves reporting due to rarity of the disease and hitherto unreported association with CML. Furthermore, the pathological diagnosis is challenging and requires a close-knit effort between the pathologist and haematologist.
机译:滤泡树突状细胞或树突状网状细胞是抗原呈递必不可少的免疫系统的重要组成部分。由这些细胞引起的恶性肿瘤并不常见,第一例报道于1986年。滤泡树突状细胞肉瘤最常见的部位是淋巴结,尤其是宫颈,腋窝和纵隔区域,但可能影响到包括头部,颈部和胃肠道在内的结外部位。在三分之一的患者中。免疫组织化学在其诊断中将其与形态相似的恶性肿瘤区分开来,起着重要作用。本报告描述了甲磺酸伊马替尼治疗6年的慢性粒细胞白血病(CML)患者的一例滤泡树突状细胞肉瘤。由于该病的罕见性以及迄今尚未报道的与CML的关联,该病例值得报告。此外,病理诊断具有挑战性,并且需要病理学家和血液学家之间的紧密合作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号